Cutler Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,300
Closed -$2K 4145
2022
Q4
$2K Buy
13,300
+11,600
+682% +$95.5K ﹤0.01% 3688
2022
Q3
$5K Buy
+1,700
New +$21.1K ﹤0.01% 3647
2021
Q3
Sell
-3,000
Closed -$6K 5940
2021
Q2
$6K Buy
+3,000
New +$26K ﹤0.01% 4300
2020
Q2
Sell
-1,500
Closed -$5K 4560
2020
Q1
$5K Sell
1,500
-4,000
-73% -$52.2K ﹤0.01% 3077
2019
Q4
$10K Buy
5,500
+2,100
+62% +$42.3K ﹤0.01% 2633
2019
Q3
$3K Buy
+3,400
New +$67.6K ﹤0.01% 3294

Other funds holding GOSS

Cutler Group's GOSS Position: Q3 2023 in Review

Cutler Group sold out of Gossamer Bio (GOSS) in Q3 2023, closing a stake of 1,400 shares — an estimated $1K sold.

Cutler Group first reported a position in GOSS in Q4 2019 and held it in 9 quarters. The position peaked at $31K in Q3 2022. 95 funds tracked by Wall St. Rank hold GOSS as of Q3 2023.

  • Cutler Group reported no remaining Gossamer Bio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,400 Gossamer Bio shares in Q3 2023, an estimated $1K.
  • Cutler Group first reported a position in Gossamer Bio in Q4 2019 and held it in 9 quarters.
  • Cutler Group's Gossamer Bio position peaked at $31K in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.